Table 1.
Sample | Cancer | Placebo (mg) | APG 157 (mg) | Ethnicity | Gender | Age | Site | Stage | P16 expression | Smoking history |
---|---|---|---|---|---|---|---|---|---|---|
P1 | Yes | NA | 100 | White | Male | 66 | Left tonsil | T2N1 | Positive | Quit 1985 |
P2 | No | 100 | NA | White | Male | 34 | – | – | – | Former occasionally |
P3 | Yes | 100 | NA | White | Male | 68 | Tongue | T2N0 | Negative | No |
P4 | No | 200 | NA | Black | Male | 49 | – | – | – | 1/2 PPD |
P5 | No | NA | 200 | Black | Male | 56 | – | – | – | No |
P6 | No | NA | 200 | Black | Male | 55 | – | – | – | 1PPD |
P7 | Yes | NA | 200 | Black | Male | 46 | Hypopharynx | T4N2b | Negative | Quit 1985 |
P8 | Yes | 200 | NA | White | Male | 70 | FOM | T2N2b | Negative | 1PPD |
P9 | Yes | 200 | NA | White | Male | 62 | Right tonsil | T3N2b | Positive | 1/2PPD |
P10 | Yes | NA | 200 | White | Male | 64 | FOM | T4aN2a | ND | 2 PPD |
NA, not applicable; ND, no data available; FOM, floor of mouth; PPD, packs per day; “-” healthy subjects without cancer.